TCHEN, John
SIMON, Quentin http://orcid.org/0000-0002-2383-2809
CHAPART, Léa http://orcid.org/0009-0008-9720-1146
THAMINY, Morgane K. http://orcid.org/0009-0002-4842-0277
VIBHUSHAN, Shamila http://orcid.org/0000-0001-6196-2295
SAVEANU, Loredana http://orcid.org/0000-0003-3138-7968
LAMRI, Yasmine
SAIDOUNE, Fanny
PACREAU, Emeline
PELLEFIGUES, Christophe http://orcid.org/0000-0001-7036-0763
BEX-COUDRAT, Julie
KARASUYAMA, Hajime http://orcid.org/0000-0003-0689-0836
MIYAKE, Kensuke http://orcid.org/0000-0003-1149-3755
HIDALGO, Juan http://orcid.org/0000-0003-0921-1122
FALLON, Padraic G. http://orcid.org/0000-0002-8401-7293
PAPO, Thomas
BLANK, Ulrich http://orcid.org/0000-0002-2661-2983
BENHAMOU, Marc
HANOUNA, Guillaume
SACRE, Karim http://orcid.org/0000-0002-6544-234X
DAUGAS, Eric
CHARLES, Nicolas http://orcid.org/0000-0002-5416-5834
Funding for this research was provided by:
Agence Nationale de la Recherche (ANR-19-CE17-0029 BALUMET, ANRPIA-10-LABX-0017 INFLAMEX)
Fondation pour la Recherche Médicale (EQU201903007794)
Institut National de la Santé et de la Recherche Médicale (UMR1149)
Centre National de la Recherche Scientifique (EMR8252)
Ministerio de Economía y Competitividad (RTI2018-101105-B-I00)
Université Paris-Cité
Article History
Received: 30 August 2023
Accepted: 4 April 2024
First Online: 22 April 2024
Competing interests
: N.C. holds a patent related to compositions and methods for treating or preventing lupus (W020120710042). C.P. and N.C. are coinventors of the patent WO2016128565A1 related to the use of PTGDR-1 and PTGDR-2 antagonists for the prevention or treatment of systemic lupus erythematosus. No other disclosures relevant to this article are reported. The remaining authors declare no competing interests relevant to this article.